Sign In
Buy FBIO
$2.61
-0.0400 (-1.51%)
At Close: Jun 03, 2026
FORTRESS REIT LIMITED – Change to the board of directors and change in function of director - SENS
07:43am, Monday, 29'th Jun 2020
Sens announcement for FORTRESS REIT LIMITED – Change to the board of directors and change in function of director - SENS
Alpha Bank A E : nears deal to sell bad debt portfolio to Fortress - sources | MarketScreener
02:16pm, Thursday, 25'th Jun 2020Alpha Bank nears deal to sell bad debt portfolio to Fortress: sources
02:16pm, Thursday, 25'th Jun 2020
Alpha Bank , Greece's fourth-largest lender, is close to finalising a deal to sell a portfolio of bad loans worth more than 1 billion euros to U.S. investment manager Fortress Group, three sources fam
Fortress fund pares back on Jamaica as equities sink
05:11am, Wednesday, 24'th Jun 2020
Fortress Fund Managers, operators of the Caribbean Growth Fund based in Barbados, earned negative returns on its Jamaican investments for a year now, which formerly led the gains in the fund. But: “
Bristol Myers Squibb : Early Pipeline & Immuno-Oncology Presentation | MarketScreener
03:27pm, Monday, 22'nd Jun 2020Mustang Bio (NASDAQ:MBIO) Shares Gap Up to $3.40
06:16am, Friday, 19'th Jun 2020
Mustang Bio Inc (NASDAQ:MBIO) gapped up before the market opened on Wednesday . The stock had previously closed at $3.27, but opened at $3.40. Mustang Bio shares last traded at $3.45, with a volume of
Fortress Gets U.S. Backing in Apple Patent ‘Puppeteering’ Suit - BNN Bloomberg
08:20am, Thursday, 18'th Jun 2020
The Trump administration will join Fortress Investment Group in court Thursday in an antitrust fight with Apple Inc. and Intel Corp. with billions of dollars in patent royalties at stake.
Fortress Biotech to Present at the Raymond James Human Health Innovation Conference
12:30pm, Monday, 15'th Jun 2020
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential
-$0.28 EPS Expected for Mustang Bio Inc (NASDAQ:MBIO) This Quarter
07:30am, Monday, 15'th Jun 2020
Wall Street analysts expect Mustang Bio Inc (NASDAQ:MBIO) to announce earnings per share of ($0.28) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Mustang Bio�
Japanese Court Upheld Former Mt Gox CEO's Conviction for Manipulating Data | Bitcoin News
10:26pm, Friday, 12'th Jun 2020
A Japanese high court upheld the Tokyo-based lower court’s decision to reject the former CEO of Mt Gox, Mark Karpeles, appeal.
Mustang Bio Announces Pricing of Public Offering of Common Stock
01:00pm, Thursday, 11'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential
Global CAR-T Therapy Market Assessment 2020-2030 - ResearchAndMarkets.com
12:00am, Thursday, 11'th Jun 2020
The
Here is What Hedge Funds Think About Fortress Biotech Inc (FBIO)
08:18pm, Wednesday, 10'th Jun 2020
In this article we will check out the progression of hedge fund sentiment towards Fortress Biotech Inc (NASDAQ:FBIO) and determine whether it is a good investment right now. We at Insider Monkey like
Mustang Bio Announces Proposed Public Offering of Common Stock
08:01pm, Wednesday, 10'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
